From the Editor-in-Chief
Strategies for prostate cancer screening and surveillance are still being refined.
by William G. Nelson, MD, PhD
Cancer Today's Winter 2015/2016 issue describes advances in lung cancer, big data and more.
by Kevin McLaughlin
Should the Age to Buy Cigarettes Be 21? | Reducing Re-excision | Coming Out About Cancer | The Oncology Nurse Will See You Now | Uterine Cancer Rates on the Rise | Cancer Immunotherapies Continue to Make Headway
Your Cancer Guide
Live for today, but plan for tomorrow and beyond.
by Hester Hill Schnipper
Caregiving With Confidence
Make time for yourself so you can be strong for your loved ones.
by Marc Silver
Big data, using high-powered computers to gather and analyze massive amounts of patient information, promises to revolutionize cancer care. But experts say patient concerns about privacy and other issues must be addressed.
by Stephen Ornes
During her treatment for breast cancer, biomedical engineer Jessica Winter challenged her laboratory to bring its discoveries to patients more quickly.
by Chris Palmer
Yesterday & Today
Literary realist John Updike used the scaffold of his own life, including his lung cancer diagnosis, to explore the shared experiences of our time.
by Sue Rochman
While much of the Western world was tightening restrictions on smoking, one European nation, the Netherlands, found itself embroiled in a political struggle between individual freedoms and public health.
by Cynthia Ryan
Coming to terms with feelings and emotions about weight gain and weight loss is often part of a cancer patient's experience.
Fuel Up With a Smoothie | Get Your Move On
Author Judith Kelman describes how cancer patients benefit from writing about their personal stories.
by Betty Russell
Staying healthy with a compromised immune system, dealing with a second cancer diagnosis, and determining if treatment side effects are normal or not.
Cindy's Legacy provides financial support to families who are affected by cancer.
by Eileen Glanton Loftus
Jared Levinthall, Carol Dellinger, Anne Ha.
In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.
by Kate Yandell
Advocates shared their stories and projects at the AACR Annual Meeting.
National Cancer Institute director Norman “Ned” Sharpless meets with advocates and outlines areas of focus for the agency.
by Marci A. Landsmann
The Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.
by Kevin McLaughlin
To increase efficacy and combat resistance to checkpoint inhibitors, many clinical trials are centered on combining an immune checkpoint inhibitor with a second drug.
The FDA expands use of durvalumab to non–small cell lung cancer.
A collaborative initiative seeks to improve understanding of cancer outcomes in African-American patients through genomic sequencing.
The Financial Toll of Cancer
donate to the AACR